AnaptysBio's market cap is currently $574.19M. The company's EPS TTM is $-6.069; its P/E ratio is ―; AnaptysBio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.62. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 17.16M	$ 10.29M	$ 63.17M	$ 75.00M	$ 8.00M
Gross Profit	$ 14.78M	$ 7.95M	$ -35.32M	$ -5.03M	$ -91.34M
Operating Income	$ -164.41M	$ -115.15M	$ -56.81M	$ -23.88M	$ -107.43M
EBITDA	$ -143.16M	$ -105.26M	$ -55.71M	$ -19.37M	$ -95.93M
Net Income	$ -163.62M	$ -128.72M	$ -57.19M	$ -19.92M	$ -97.34M
Balance Sheet
Cash & Short-Term Investments	$ 390.90M	$ 441.24M	$ 548.10M	$ 393.65M	$ 374.23M
Total Assets	$ 452.39M	$ 610.38M	$ 643.07M	$ 416.55M	$ 435.20M
Total Debt	$ 17.81M	$ 19.45M	$ 20.95M	$ 342.00K	$ 2.25M
Net Debt	$ -18.15M	$ -51.86M	$ -474.77M	$ -250.11M	$ -168.77M
Total Liabilities	$ 364.29M	$ 348.28M	$ 286.64M	$ 19.82M	$ 30.19M
Stockholders' Equity	$ 88.10M	$ 262.10M	$ 356.43M	$ 396.73M	$ 405.01M
Cash Flow
Free Cash Flow	$ -121.61M	$ -73.95M	$ -47.29M	$ -14.73M	$ -70.32M
Operating Cash Flow	$ -120.80M	$ -73.59M	$ -45.92M	$ -14.16M	$ -69.52M
Investing Cash Flow	$ 144.75M	$ -394.85M	$ 38.84M	$ 94.47M	$ 131.43M
Financing Cash Flow	$ -59.30M	$ 44.02M	$ 252.30M	$ -879.00K	$ -4.49M

Currency in USD

AnaptysBio Earnings and Revenue History

Income Statement >

AnaptysBio Debt to Assets

Balance Sheet >

AnaptysBio Cash Flow

Cash Flow >

AnaptysBio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing